However, overexpression of DAPK3 strengthened the degradation of PRBM1 induced by UBE3A WT or T508A mutant (Fig. 4h, i), which was independent of the kinase activity of DAPK3 in renal cancer cells (Fig. 4i). Here, DAPK3 is linked to renal carcinoma.